The Role of the Private Sector in Global Health Security
Charlotte Ersboll, Senior Adviser, UN Global Compact
Luc Debruyne, President, Global Vaccines, GlaxoSmithKline
Seamus O’Brien, Executive Director, Global External Scientific Affairs, Pfizer
Michikazu Koshiba, Head, Center on Global Health Architecture, Mitsubishi UFJ Research & Consulting Co Ltd
Mr Arnaud Bernaert, Head of Global Health and Healthcare Industries, World Economic Forum
Hilary Thomas, CMO and Partner, KPMG
Professor Charlotte Watts, Chief Scientific Adviser, DFID
Mr. Ikuo Takizawa, Deputy Director General, Human Development Department, JICA
Dr Guénaël Rodier, Director Department of Global Capacities, Alert & Response, Outbreaks and Health Emergencies ,WHO
Dr Lucica Ditiu, Executive Director, Stop TB Partnership
Professor Tom Kariuki, Director of the Alliance for Accelerating Excellence in Science in Africa (AESA), African Academy of Sciences
Dr Päivi Sillanaukee, Permanent Secretary of the Ministry of Social Affairs and Health of Finland
The establishment of working partnerships between governments, civil society and the private sector to strengthen national health systems and improve public health outcomes often result in debate. Despite this, the advances made in public health over the last 20 years, and the universally agreed Sustainable Development Goals demonstrate the value of private sector involvement in global health initiatives. Nevertheless, there are still many associated issues that raise legitimate concerns among public health stakeholders: conflicts of interest – both perceived and real – are often used as arguments against involving the private sector, as are the governance structures and financing models that underpin collaborative efforts.
This one-day conference, organized by the Chatham House Centre on Global Health Security, aims to address themes surrounding the role of the private sector in global health initiatives. The conference will bring together a range of high-level stakeholders from academia, commercial for-profit companies, foundations and other prominent global health partners to stimulate discussion and identify the opportunities and challenges related to the private sector’s engagement in improving global health.
In partnership with Mitsubishi UFJ Research and Consulting.
With kind support from Pfizer and Johnson and Johnson.
The Chatham House Rule
To enable as open a debate as possible, this event will be held under the Chatham House Rule.